A pharmaceutical composition comprises (a) a compound that induces an increase in intracellular levels of cyclic adenosine monophosphate (cAMP), in particular, forskolin and (b) sodium cholate. Preferably, the formulation is for use in the treatment of male pattern baldness (androgenic alopecia) and may preferably be administered orally in the form of a capsule.
